GSE227127 diclofenac 1 v 0 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE227127_diclofenac_1_v_0_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE227127_diclofenac_1_v_0_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE227127_diclofenac_1_v_0_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE227127_diclofenac_1_v_0_human_up.

Results found

Linked to

 

Label

Description

 

Gene

growth arrest specific 5

Gene

Pvt1 oncogene

Gene

long intergenic non-protein coding RNA 662

Gene

metastasis associated lung adenocarcinoma transcript 1

Gene

HERC2 pseudogene 2

Gene

oligodendrocyte maturation-associated long intergenic non-coding RNA

Gene

p53 upregulated regulator of p53 levels

Gene

MIR34A host gene

Gene

TALAM1 transcript, MALAT1 antisense RNA

Gene

H2B clustered histone 20, pseudogene

  • Gene

    growth arrest specific 5



  • Gene

    long intergenic non-protein coding RNA 662


  • Gene

    metastasis associated lung adenocarcinoma transcript 1


  • Gene

    HERC2 pseudogene 2


  • Gene

    oligodendrocyte maturation-associated long intergenic non-coding RNA


  • Gene

    p53 upregulated regulator of p53 levels



  • Gene

    TALAM1 transcript, MALAT1 antisense RNA


  • Gene

    H2B clustered histone 20, pseudogene

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.